• Je něco špatně v tomto záznamu ?

Liver-Specific, but Not Retina-Specific, Hepcidin Knockout Causes Retinal Iron Accumulation and Degeneration

BH. Baumann, W. Shu, Y. Song, J. Sterling, Z. Kozmik, S. Lakhal-Littleton, JL. Dunaief,

. 2019 ; 189 (9) : 1814-1830. [pub] 20190706

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006172

Grantová podpora
FS/12/63/29895 British Heart Foundation - United Kingdom
R01 EY015240 NEI NIH HHS - United States
T32 AI070077 NIAID NIH HHS - United States
T32 GM007170 NIGMS NIH HHS - United States

The liver secretes hepcidin (Hepc) into the bloodstream to reduce blood iron levels. Hepc accomplishes this by triggering degradation of the only known cellular iron exporter ferroportin in the gut, macrophages, and liver. We previously demonstrated that systemic Hepc knockout (HepcKO) mice, which have high serum iron, develop retinal iron overload and degeneration. However, it was unclear whether this is caused by high blood iron levels or, alternatively, retinal iron influx that would normally be regulated by retina-produced Hepc. To address this question, retinas of liver-specific and retina-specific HepcKO mice were studied. Liver-specific HepcKO mice had elevated blood and retinal pigment epithelium (RPE) iron levels and increased free (labile) iron levels in the retina, despite an intact blood-retinal barrier. This led to RPE hypertrophy associated with lipofuscin-laden lysosome accumulation. Photoreceptors also degenerated focally. In contrast, there was no change in retinal or RPE iron levels or degeneration in the retina-specific HepcKO mice. These data indicate that high blood iron levels can lead to retinal iron accumulation and degeneration. High blood iron levels can occur in patients with hereditary hemochromatosis or result from use of iron supplements or multiple blood transfusions. Our results suggest that high blood iron levels may cause or exacerbate retinal disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006172
003      
CZ-PrNML
005      
20200525111645.0
007      
ta
008      
200511s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ajpath.2019.05.022 $2 doi
035    __
$a (PubMed)31287995
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Baumann, Bailey H $u F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, Philadelphia, Pennsylvania.
245    10
$a Liver-Specific, but Not Retina-Specific, Hepcidin Knockout Causes Retinal Iron Accumulation and Degeneration / $c BH. Baumann, W. Shu, Y. Song, J. Sterling, Z. Kozmik, S. Lakhal-Littleton, JL. Dunaief,
520    9_
$a The liver secretes hepcidin (Hepc) into the bloodstream to reduce blood iron levels. Hepc accomplishes this by triggering degradation of the only known cellular iron exporter ferroportin in the gut, macrophages, and liver. We previously demonstrated that systemic Hepc knockout (HepcKO) mice, which have high serum iron, develop retinal iron overload and degeneration. However, it was unclear whether this is caused by high blood iron levels or, alternatively, retinal iron influx that would normally be regulated by retina-produced Hepc. To address this question, retinas of liver-specific and retina-specific HepcKO mice were studied. Liver-specific HepcKO mice had elevated blood and retinal pigment epithelium (RPE) iron levels and increased free (labile) iron levels in the retina, despite an intact blood-retinal barrier. This led to RPE hypertrophy associated with lipofuscin-laden lysosome accumulation. Photoreceptors also degenerated focally. In contrast, there was no change in retinal or RPE iron levels or degeneration in the retina-specific HepcKO mice. These data indicate that high blood iron levels can lead to retinal iron accumulation and degeneration. High blood iron levels can occur in patients with hereditary hemochromatosis or result from use of iron supplements or multiple blood transfusions. Our results suggest that high blood iron levels may cause or exacerbate retinal disease.
650    _2
$a zvířata $7 D000818
650    _2
$a hematoretinální bariéra $7 D001813
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hepcidiny $x fyziologie $7 D064451
650    _2
$a železo $x metabolismus $7 D007501
650    _2
$a přetížení železem $x etiologie $x metabolismus $x patologie $7 D019190
650    _2
$a játra $x metabolismus $x patologie $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    _2
$a retina $x metabolismus $x patologie $7 D012160
650    _2
$a degenerace retiny $x etiologie $x metabolismus $x patologie $7 D012162
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Shu, Wanting $u F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, Philadelphia, Pennsylvania; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China.
700    1_
$a Song, Ying $u F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, Philadelphia, Pennsylvania.
700    1_
$a Sterling, Jacob $u F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, Philadelphia, Pennsylvania.
700    1_
$a Kozmik, Zbynek $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Academy of Sciences of the Czech Republic (ASCR), Prague, Czech Republic.
700    1_
$a Lakhal-Littleton, Samira $u Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
700    1_
$a Dunaief, Joshua L $u F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, Philadelphia, Pennsylvania. Electronic address: jdunaief@pennmedicine.upenn.edu.
773    0_
$w MED00009121 $t The American journal of pathology $x 1525-2191 $g Roč. 189, č. 9 (2019), s. 1814-1830
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31287995 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200525111646 $b ABA008
999    __
$a ok $b bmc $g 1525030 $s 1096228
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 189 $c 9 $d 1814-1830 $e 20190706 $i 1525-2191 $m American journal of pathology $n Am J Pathol $x MED00009121
GRA    __
$a FS/12/63/29895 $p British Heart Foundation $2 United Kingdom
GRA    __
$a R01 EY015240 $p NEI NIH HHS $2 United States
GRA    __
$a T32 AI070077 $p NIAID NIH HHS $2 United States
GRA    __
$a T32 GM007170 $p NIGMS NIH HHS $2 United States
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...